Lung cancer is the most common cancer. Small-cell and non-small cell lung cancer is a disease in which malignant cells develop from tissues of the lung. There are several types of non-small cell lung cancer: squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. It is the most common kind of lung cancer.
Screening is looking for cancer before a person has any symptoms. UCLA is a leading institution in lung cancer screening. The recommendations for lung cancer screening are based on a several studies that carefully evaluated low-dose CT scanning to look for lung cancer in high risk patients. The most significant study was the National Lung Screening Trial (NLST).
The benefits of lung cancer screening include:
More information on UCLA lung cancer screening can be found at our website: https://www.uclahealth.org/lungcancer/lung-screening-clinic.
In addition to a physical examination, laboratory tests and imaging studies are needed. These tests include:
Treatment depends on the type of cancer, the stage (size of tumor and whether it has spread to other organs), whether the cancer has mutations in certain genes, and the patient’s general health. In addition to traditional surgical resection, chemotherapy, targeted systemic therapy, and radiation therapy, our interventional oncology team also offer the following image-guided minimal invasive therapies:
For more information or to schedule an appointment with one of our IR physicians, please call 310-481-7545.